Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Federal Trade Commission
Merck
Queensland Health
Cerilliant
Cipla
Healthtrust
AstraZeneca
Colorcon
Covington

Generated: December 10, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018676

« Back to Dashboard

NDA 018676 describes HEPATAMINE 8%, which is a drug marketed by B Braun and is included in one NDA. It is available from one supplier. Additional details are available on the HEPATAMINE 8% profile page.

The generic ingredient in HEPATAMINE 8% is amino acids. There are three hundred and forty-one drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the amino acids profile page.

Summary for 018676

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 018676

Ingredient-typeAmino Acids

Suppliers and Packaging for NDA: 018676

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
HEPATAMINE 8% amino acids INJECTABLE;INJECTION 018676 NDA B. Braun Medical Inc. 0264-9371 0264-9371-55 6 CARTON in 1 CASE (0264-9371-55) > 1 CONTAINER in 1 CARTON > 500 mL in 1 CONTAINER

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength8% (8GM/100ML)
Approval Date:Aug 3, 1982TE:RLD:No

Expired Orange Book Patents for NDA: 018676

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
B BraunHEPATAMINE 8%amino acidsINJECTABLE;INJECTION018676-001Aug 3, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Harvard Business School
Boehringer Ingelheim
Daiichi Sankyo
Covington
Teva
McKesson
QuintilesIMS
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot